MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Equity benchmarks ended a four-day losing streak with modest gains on Tuesday, as easing CPI inflation lifted investor sentiment. Hopes of a potential rate cut spurred buying interest, pushing all NSE ...

Foreign investors turned net buyers in Indian equities on Tuesday after heavy selling a day prior, while domestic ...

Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...

Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for ...

India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for ...

Indian benchmark Sensex and Nifty indices rebounded on Tuesday, snapping a four-day losing streak, as a softer-than-expected ...

Sun Pharmaceutical Industries said that it has launched hair-loss treatment drug LEQSELVI (deuruxolitinib) in the U.S.

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

Going forward, Aadhaar-based OTP verification has been made compulsory for Tatkal ticket bookings on IRCTC. This requirement ...